Last update 11 Jul 2025

Docetaxel

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
BEIZRAY, DEP® docetaxel, Docetaxel Hydrate
+ [59]
Target
Action
inhibitors
Mechanism
Tubulin inhibitors
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
RegulationAccelerated Approval (United States), Priority Review (China)
Login to view timeline

Structure/Sequence

Molecular FormulaC43H55NO15
InChIKeyYWKYKORYUFJSCV-XKIQGVRMSA-N
CAS Registry148408-66-6

External Link

KEGGWikiATCDrug Bank
D07866Docetaxel

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Early Stage Breast Carcinoma
European Union
22 May 2012
Early Stage Breast Carcinoma
Iceland
22 May 2012
Early Stage Breast Carcinoma
Liechtenstein
22 May 2012
Early Stage Breast Carcinoma
Norway
22 May 2012
Gastroesophageal junction adenocarcinoma
European Union
22 May 2012
Gastroesophageal junction adenocarcinoma
Iceland
22 May 2012
Gastroesophageal junction adenocarcinoma
Liechtenstein
22 May 2012
Gastroesophageal junction adenocarcinoma
Norway
22 May 2012
Metastatic castration-resistant prostate cancer
European Union
22 May 2012
Metastatic castration-resistant prostate cancer
European Union
22 May 2012
Metastatic castration-resistant prostate cancer
Iceland
22 May 2012
Metastatic castration-resistant prostate cancer
Iceland
22 May 2012
Metastatic castration-resistant prostate cancer
Liechtenstein
22 May 2012
Metastatic castration-resistant prostate cancer
Liechtenstein
22 May 2012
Metastatic castration-resistant prostate cancer
Norway
22 May 2012
Metastatic castration-resistant prostate cancer
Norway
22 May 2012
Metastatic gastric adenocarcinoma
European Union
22 May 2012
Metastatic gastric adenocarcinoma
Iceland
22 May 2012
Metastatic gastric adenocarcinoma
Liechtenstein
22 May 2012
Metastatic gastric adenocarcinoma
Norway
22 May 2012
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Castration-sensitive prostate cancerPhase 3
United Kingdom
11 Jun 2024
Advanced Lung Non-Small Cell CarcinomaPhase 3
China
08 Jun 2023
Hormone-dependent prostate cancerPhase 3
Austria
16 May 2023
Hormone-dependent prostate cancerPhase 3
Germany
16 May 2023
Advanced Malignant Solid NeoplasmPhase 3
India
29 Apr 2021
Solid tumorPhase 3
India
29 Apr 2021
Circulating Neoplastic CellsPhase 3
United Kingdom
11 Jan 2017
Metastatic Prostate CarcinomaPhase 3
United Kingdom
11 Jan 2017
HER2 Positive Breast CancerPhase 3
United States
14 Mar 2016
HER2 Positive Breast CancerPhase 3
China
14 Mar 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
350
Docetaxel + Standard of Care (RT+ADT)
nikypbwvym(kabfiktezn) = ldrgwuxsfp bvgrhbhhit (fcjohxecmi )
Positive
30 May 2025
(Standard of Care (RT+ADT))
nikypbwvym(kabfiktezn) = ykpshcgzrx bvgrhbhhit (fcjohxecmi )
Not Applicable
Metastatic Prostate Carcinoma
PTEN inactivation | Decipher score
832
ADT + Docetaxel +/- Zoledronic Acid
xmlgzbkxtq(epxqzjxpna): HR = 0.57 (95% CI, 0.42 - 0.76), P-Value = 0.002
Positive
30 May 2025
Phase 1/2
25
aaxxglafbc(ntdqzkwmow) = daoxioopse jlcuiztzih (cyyyzjrvqm )
Positive
30 May 2025
Phase 1
-
6
qhubuojmpc(oitnjsvfcj) = No BH011-related serious adverse events (AEs) occurred crhkthcovl (fxjaxnusgg )
Positive
30 May 2025
Not Applicable
-
696
Early Docetaxel Therapy
eghvjdthny(kgwkncxxqb) = zdtnqeqqki igvkzpfcmj (gzctcbvckp )
Positive
30 May 2025
Delayed Docetaxel Therapy
eghvjdthny(kgwkncxxqb) = feafhqiuly igvkzpfcmj (gzctcbvckp )
Phase 2/3
Head and Neck Neoplasms
cisplatin-ineligible
356
Concurrent Docetaxel + Radiation Therapy
tcwyqwsbry(gnzvpqbwax) = nwwgyhwmkt fijfeihgaq (ljicaedrcd, 29.9 - 44.1)
Positive
30 May 2025
Radiation Therapy Alone
tcwyqwsbry(gnzvpqbwax) = oypaxtuloy fijfeihgaq (ljicaedrcd, 17.7 - 30.3)
Not Applicable
Prostatic Cancer
prostate-specific antigen
-
enmdveqvnn(fgwobsgqhh): HR = 1.52 (95% CI, 0.87 - 2.68), P-Value = 0.14
Negative
30 May 2025
Not Applicable
76
tzxfignnvt(eezxaietoa) = Treatment with D was associated with improved PFS for metastatic ULMS compared to treatment with GT sgrwpxwcdx (panznjugnm )
Positive
30 May 2025
Not Applicable
Breast Cancer
Adjuvant
Her2 neu negative
-
Doxorubicin/cyclophosphamide combined with paclitaxel (ACT)
udzjmnpitx(bhqjswfdmr) = ygvntxjtfl ungdvzvdkd (njknbywivm )
Negative
30 May 2025
Docetaxel/cyclophosphamide (TC)
udzjmnpitx(bhqjswfdmr) = eztxmflpod ungdvzvdkd (njknbywivm )
Not Applicable
-
ayypffegoi(otgndjxpvg) = Docetaxel has been described to cause capillary leak syndrome due to decreased oncotic pressure inducing fluid leakage into the pleural, abdominal, interstitial, or pericardial space. The risk of occurrence is noted to increase with more docetaxel cycles. Although our patient did not have ascites or significant peripheral edema, she continued to have pericardial and pleural effusions. jvtdvzlyup (onowbdseqc )
-
16 May 2025
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free